01 / BIOPHARMACEUTICALS
Biosimilar
- Human Insulin rDNA
- Recombinant Granulocyte Colony Stimulating Factor – Filgrastim
- Recombinant Interferon beta-1a
- Follicle Stimulating Hormone
- Recombinant Chorionic Gonadotrophin Hormone r-hCG
- State-of-the-art cGMP facility
- 7,000 sq. meter facility with HVAC system
- Vial-to-vial single-use technology and closed processing
- Recombinant Erythropoietin
- Recombinant Interferon α
- Recombinant Pegylated Interferon
- Recombinant Pegylated GCSF